Previous Page  66 / 101 Next Page
Information
Show Menu
Previous Page 66 / 101 Next Page
Page Background

Biophysics in the Understanding, Diagnosis, and Treatment of Infectious Diseases Poster Abstracts

61

38-POS

Board 38

MALDI MSI and LCMS/MS as Tools for Gatifloxacin Distribution in Healthy Rat Brain

Adeola Shobo

, Tricia Naicker, Linda Bester, Sanil D. Singh, Glenn Maguire, Hendrik G.

Kruger, Thavendran Govender.

University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.

High mortality rates from tuberculosis (TB) remains a major concern worldwide. Besides the

scourge of pulmonary TB, extra-pulmonary TB (EPTB) is increasing in developed as well as

third-world countries. Tuberculosis meningitis (TBM) is the most common form of EPTB in

human immunodeficiency syndrome (HIV) co-infected patients, and morbidity and mortality

remains high in affected adults and children, despite the initiation of effective anti-TB therapy.

This is possibly a consequence of reduced penetration of orally administered TB drugs in the

CNS, resulting in treatment failure and drug resistance. The use of matrix-assisted laser

desorption ionization-mass spectrometry imaging techniques as a suitable alternative for the

localization of drug-tissue distribution for gatifloxacin will be able to answer questions regarding

its distribution because other available methods require nuclear labeling and the detection of

gamma rays produced by labeled compounds to localize the compound and hence causing a

modification to the original structure of the active molecule. The aim of this study was to

determine the brain distribution and the pharmacokinetic profile of gatifloxacin in healthy

Sprague-dawley rats using matrix assisted laser desorption ionization mass spectrometry imaging

(MALDI MSI) and quantitative liquid chromatography tandem mass spectrometry (LCMS/MS).

The MALDI MSI results showed the drug gradually diffused into the brain via the blood brain

barrier and into the cortical regions of the rat brain reaching Cmax of 228.48 ng/ml at 120 min

post-dose. As time elapses the drug slowly leaves the brain following the same path as it

followed on its entry into the brain and finally concentrates at the frontal cortex. Thus we have

shown that MALDI MSI is a valuable tool in the study of drug localization, which requires less

complicated sample processing with better resolution for drug distribution studies.